Fibrinolysis Compared to Thoracoscopy for Pleural Infection
Status:
Completed
Trial end date:
2019-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this prospective randomized clinical trial is to compare two currently
accepted standard-of-care treatment strategies: Medical thoracoscopy as compared to
instillation of intrapleural tissue Plasminogen Activator (TPA) and human recombinant
Deoxyribonuclease (DNase) for the management of empyema or complicated parapneumonic effusion
(CPPE) in adults.